A new eBook from electronic publisher Quicklook Books aims to give outsiders a broad overview of the veterinary profession.

According to author, veterinary surgeon Bob Lehner, Quicklook@Vets offers readers the opportunity to get below the surface of the veterinary working practice and gain insight into the profession, without becoming 'bogged down' in complicated medical terminology.

He said: "The veterinary world, although considered by many to be an enthralling subject, is accessible to very few people. Texts are, more often than not, written for veterinary graduates instead of the general public.

"In Quicklook@Vets, I wanted to explore all the aspects of this exciting subject in a clear, coherent manner, without unnecessary jargon, to enable anyone to read and learn about the captivating world of veterinary practice."

As a vet with over 35 years of experience, Bob Lehner worked with a wide range of animals and has experience in commercial deer farming, working with zoo animals and as a veterinary surgeon for the pharmaceutical industry. Now retired, Bob Lehner works part-time in practice, as an inspector for the RCVS Practise Standards Scheme and work with an animal charity in Botswana neutering feral village dogs.

The book is available for download here 

Nestlé Purina is launching a new diet this month which, according to the company, helps delay the canine brain ageing process.

The diet, Pro Plan Senior 7+ Original, is enriched with medium chain triglycerides (MCTs). Research carried out by Nestlé Purina and published online in the British Journal of Nutrition (here's the abstract), apparently demonstrates improvements in senior dogs' memory, learning capacity and ability to adapt to novel situations when fed on this MCT-enriched formula.¹ According to the company, the MCTs provide neurons with a readily accessible source of energy to counteract the decline in glucose metabolism that occurs naturally in ageing dogs, thus maximising brain function with demonstrable improvements in cognitive function.

Veterinary surgeon, Barton Stephen, BVM&S MRCVS, veterinary columnist for The People said: "When treating brain ageing or CCD in senior dogs I believe we vets need to adopt a more holistic approach. We can treat diseases like heart failure and kidney disease and offer advice on exercise, joint care and weight control. All of these can improve quality of life and encourage a pain free existence, but until now we have had nothing proven to help dogs stay younger for longer. This innovative new dog food has the added advantage of staving off cognitive decline which owners find very distressing."

For more information on Pro Plan Senior 7+ Original and the Pro Plan, diet range, please contact your Veterinary Business Development Manager or contact Nestlé Purina PetCare, telephone: 0800 212 161 (Freephone)

Reference:
^¹ Dietary supplementation with medium-chain TAG has long-lasting cognition-enhancing effects in aged dogs. British Journal of Nutrition (Pan et al 2010)

Following a nationwide search to find the UK's top veterinary professionals for 2010, Petplan has announced the winners of the Veterinary Awards. 

The Petplan Veterinary Awards recognise and applaud staff and practices throughout the country that have delivered an exceptional level of care to the nation's pets and their owners.   

Alison Andrew, Petplan's Marketing Manager, says she is thrilled by the ongoing success of the awards. "Britain is known to be an animal-loving nation and with millions of households owning cats and dogs, pets play a central part in family life. The Petplan Veterinary Awards give us the opportunity, on behalf of all pet owners across the UK, to thank the veterinary profession for the outstanding service they provide to our pets.

"This is the 11^th year of the awards and we received over 1800 nominations, which really highlights the high regard that the profession and pet owners have for these awards."

VET OF THE YEAR
Mike Hewitt, Wendover Heights Veterinary Centre, Buckinghamshire
Having worked in the profession for over 20 years Mike is highly respected by clients, valued by colleagues and loved by pets. Having received so many heartfelt customer nominations, Mike's constant professionalism and approachable manner shone through.

VET NURSE OF THE YEAR
Louise Want, Feldon Veterinary Centre, Warwickshire
The constant support and care Louise provides to both her colleagues and clients really stood out. She is a great inspiration to all and having worked in the veterinary profession for 30 years, Louise is as passionate and dedicated, as when she first started.

VET RECEPTIONIST OF THE YEAR
Carol Dawson, Kingsteignton Veterinary Group, Devon
Carol's compassionate and professional manner really impressed all the judges. Clients instantly feel at ease because of her caring smile and welcoming attitude, while her colleagues find her a great inspiration.

VET PRACTICE OF THE YEAR
Mill House Veterinary Surgery and Hospital, Norfolk     
Mill House Veterinary Surgery and Hospital provides an incredibly high level of service to their clients, and as a collective are extremely dedicated and welcoming. Taking pride in their work they are known by their clients for being efficient, friendly and helpful.

CEVA Animal Health has updated its practice support materials to include an all-encompassing D.A.P. client leaflet, a website and a new vet detailer.

The new materials, which also include a D.A.P. and Feliway reference guide containing details of 31 published trials into the practical applications of pheromones, focus on using D.A.P. to prevent stress at key stages of a dog's life. Particular attention is paid to the benefits of fitting a D.A.P. Collar during early puppy consults in order to help prepare dogs for the modern world and helping to prevent anxiety-related problems such as separation anxiety and noise phobia, developing in later life. In addition, the vet brochure will draw practitioners' attention to the times in a dog's life when owners are particularly concerned about their dog becoming stressed including events like trips to boarding kennels.

Lucy Brett, product manager at CEVA Animal Health, said: "Over the last three years eight different trials have been published looking at the use of pheromones to reduce canine stress. The latest data backs up what we have believed for some time - that the management of stress during socialisation is vital if dogs are to grow into emotionally balanced and confident adult dogs.  We now have a much better idea of the impact of allowing puppies to get stressed or overwhelmed during socialisation and the difference providing pheromone support in the form of a D.A.P. Collar can make."

For further details, or for information on CEVA's range of educational resources for veterinary professionals interested in feline and canine behaviour, please contact your CEVA Animal Health representative or call 01494 781510.

Bayer Animal Health, manufacturer of Advocate, is launching an advertising campaign to support its 'Be Lungworm Aware' initiative, which aims to educate pet owners on the spread of Angiostrongylus vasorum and encourage them to seek advice from their local veterinary practice.

The campaign will see a new TV 'public information' style advertisement targeting dog owners.  It will air on 20 national TV channels during April including ITV1, 2 and 3, Sky 1, 2 and 3, More 4 and Film4, with air time dedicated to GMTV and daytime ITV.

The TV advertising campaign will focus on the parasite's intermediate hosts - slugs and snails - and the ease in which dogs can become infected with the parasite by picking up something as simple as a toy with a slug attached to it.

Print advertisements will also be running in national newspapers and women's consumer magazines with a focus on publications read by pet owners.

Marketing support material is available for veterinary practices wishing to participate in the 'Be Lungworm Aware' initiative.  For further details, or to order the new practice materials, please contact your Bayer representative or ring 0845 2574798 quoting 'Be Lungworm Aware'.

A Royal College of Veterinary Surgeons audit panel is to visit UK veterinary schools to assess how Extra-Mural Studies (EMS) is being carried out, identify good practice and make recommendations for improvement. The exercise is part of a package of measures which aims to improve the way that EMS helps veterinary undergraduates to gain skills and knowledge in a practice environment.

RCVS Council agreed to the implementation of proposals made by a Working Party set up to review the whole EMS process in November 2009. While the EMS system was largely agreed to be valuable and working well, some areas were identified for improvement. Many of the recommendations centred on a better understanding amongst all parties involved - students, practices and vet schools - of the aims and objectives of EMS for the student, and improved communication about expectations and outcomes.

As a first step, the Education Policy and Specialisation Committee has put in place an audit of EMS at the veterinary schools. It has commissioned Dr Barry Johnson, who led the original Working Party, together with practitioners David Black, David Wadsworth and Dr Chris Chesney, to follow through individual cases, talking to the students, practitioners and clinical tutors and EMS co-ordinators at the vet schools, to build a picture of how administration, communication and follow-up is managed.

Barry said: "The objective of the audit is to identify areas of good practice that can be shared, and identify where improvements could be made - it will also promote dialogue between practices and the schools. The exercise will be repeated over the next couple of years to track changes."

The first audit took place at the Royal Veterinary College in February, as part of the full RCVS visitation of the undergraduate degree programme. The EMS audit panel will report its initial findings in June.

The full report and recommendations from the EMS Working Party can be viewed at www.rcvs.org.uk/EMS.

US company Midmark is running a UK prize draw to win a Cardell 9401 blood pressure monitor worth nearly £2000.

To enter the draw, click here.

Dogs Trust has come out firmly against RSPCA-supported proposals to re-introduce the dog licence.

The dog welfare charity says it does not believe re-introducing the dog licence would provide a welfare benefit for dogs. It has also expressed surprise at the RSPCA position, which is that: "a licence would be hugely beneficial in addressing many animal welfare concerns stemming from overbreeding of dogs to a lack of traceable ownership." Dogs Trust has said this view is extremely naïve, that responsible owners might struggle to pay what is likely to be a punitive annual licence, and that a licence is simply a tax on dog ownership. 

Meanwhile, the RSPCA has announced the results of a survey in which 2 out of 3 pet owners said they would be in favour of a licence scheme. 76% said that a dog licence should be enforced in England to help curb problems such as 'puppy farms', stray dogs, stolen dogs and animal abandonments.

The RSPCA also says that research carried out on its behalf by Reading University clearly shows that an affordable and well-enforced dog licensing scheme could provide funding for a range of issues, most of which are currently funded poorly by central and local government. Professor Emeritus Martin Upton from Reading University's school of agriculture, policy and development, said: "Our study into the potential costs and benefits of dog licencing and registration found that such a scheme could greatly contribute to responsible dog ownership and animal welfare."

Dogs Trust says the dog licence has been shown to be an ineffective measure in the UK. In Northern Ireland, where the dog licence is still a requirement, only an estimated one-third of all dog owners currently have their dogs licensed. Northern Ireland still has the highest number of stray dogs per head of population of any region in the UK and the number of dogs put to sleep in the region represents a staggering 34% of the total UK figure.

The charity recommends compulsory microchipping as the most effective means of registration as well as identification of a dog. Unlike the dog licence, which involves an annual fee, microchipping involves just a small one-off fee (Dogs Trust offers microchipping at its centres for £10).  The benefit to responsible owners and their dogs is therefore relatively cheap and effective. Microchipping a dog should infer legal ownership and reinforces the responsibilities of the owner under the Animal Welfare Act. The introduction of compulsory microchipping would allow stray dogs to be quickly returned to their owners, make easier the identification of owners who persistently allow their dogs to stray or cause nuisance, and make all puppies traceable to their breeder, helping to reduce the widespread problem of battery farming of dogs.

A new paper by D J Bartram and D S Baldwin, published in this week's Veterinary Record, has found that veterinary surgeons are four times as likely as the general public, and around twice as likely as other healthcare professionals, to die by suicide as opposed to other causes.

Professor Bill Reilly, President of the British Veterinary Association, said: "David Bartram's research in this difficult area is to be applauded. The more we can understand about the reasons behind the high suicide rate amongst veterinary surgeons, the more the BVA and other bodies can do to support vets in crisis.

"As part of the Vetlife Steering Group, the BVA supports fantastic initiatives such as the 24-hour Vet Helpline for vets, vet nurses and veterinary students, and the Veterinary Benevolent Fund.

"The BVA's Member Services Group (MSG) also spends a lot of time looking at practical initiatives to improve individual vets' day-to day lives. The recent introduction of the mediation and representation services to help resolve issues between veterinary employees and veterinary employers is a good example of the positive ways in which the BVA can support its members in difficult situations.

"The MSG also recently produced a helpline sticker for all veterinary practices to display on the medicines cabinet and other prominent places to act as a constant reminder that help is available.

"Ours is a small profession and many vets will know a friend or colleague who has taken their own life. It is essential that this issue is kept in the open so that those who are struggling know where to turn for help."

Genitrix has launched Libromide, the first licensed formulation of potassium bromide for the treatment of canine epilepsy, following what the company believes to be the largest ever trial of dogs suffering from epilepsy.

Genitrix says the availability, for the first time, of a licensed formulation of potassium bromide should give veterinary surgeons and pet owners the reassurance that the rigorous authorisation process provides.  It ensures, for instance, that the product has been developed especially for dogs and that it is manufactured in accordance with EU regulations. It also ensures that the product has been extensively and independently trialled, proven to be efficacious without adverse reactions, and that the necessary pharmacovigilance is in place to support it.  

The company also says that the availability of a licensed product paves the way for more comprehensive information to be provided to veterinary surgeons on the use of potassium bromide in treating seizures.  The Veterinary Medicines Directorate (VMD) imposes restrictions on educational materials supplied by manufacturers of unlicensed products, an approach which has created a 'knowledge gap' among many veterinary surgeons in general practice, according to some canine epilepsy experts.

Libromide tablets are intended for use in epileptic dogs which have already commenced therapy with Phenobarbital. Phenobarbital acts to increase the effects of the GABA inhibitory neurotransmitter in the central nervous system.  Potassium bromide is synergistic with Phenobarbital and raises the seizure threshold level in epileptic dogs. 

Libromide is classified as POM-V and will be available in 325 mg tablets in packs of 100 and 500 tablets.

Rodolfo Cappello DVM PhD DipECVN MRCVS, RCVS and European Specialist in Neurology and Neurosurgery, Head of Neurology Services at North Downs Specialist Referrals, Surrey, said: "I've been successfully using potassium bromide for the treatment of epilepsy in dogs for over 15 years.  The main problem has been that it's not been licensed as a medicine.  With the launch of Libromide, potassium bromide finally achieves the status of an approved pharmaceutical.  We will now be able to monitor quality, efficacy and side effects which will enable us to offer a more professional approach to the treatment of seizures."

Howard Wilder, founder and managing director of Genitrix, added:  "Canine epilepsy is an all too common disease with estimates suggesting it affects four in every hundred dogs in the UK.  It's also an illness which is not well enough understood with the lack of up to date information available to veterinary surgeons being a contributing factor.

We felt there was an opportunity to bring a licensed product to market and have invested hundreds of thousands of pounds in the process of development and trialling Libromide.  We're delighted to make it available to veterinary professionals and hope its launch will be the first step in improving treatment approaches for this distressing disease."

Novartis Animal Health has launched Zolvix, billed as the first truly novel anthelmintic class for livestock to be launched in more than 25 years, together with a new drenching system designed to make drenching faster, easier and more accurate.

Zolvix contains a new active ingredient, monepantel, which kills all key sheep gastro-intestinal nematodes (roundworms), including those resistant to the existing treatments.

According to the company, the development of this new drench follows the persistent challenge from worms that have developed resistance to the three other classes of drench - white (benzimidazole or 1-BZ), yellow (levamisole or 2-LV) and clear (macrocyclic lactone or 3-ML) and combinations of these. Zolvix has a unique mode of action and so forms a fourth generation of anthelmintic, which will be known as the 4- AD, or orange drench class

Novartis Animal Health has prioritised the UK and Ireland as key launch countries for Zolvix to provide their sheep farmers with an answer to the pressing challenge of increasing anthelmintic resistance.

Lesley Stubbings, an Independent sheep consultant and Sustainable Control of Parasites in Sheep (SCOPS) panel member, said: "Resistance has become an ever increasing threat since the last new anthelmintic group was introduced to the UK market more than 25 years ago. Zolvix offers farmers a valuable opportunity to maintain good worm control and prolong the effective life of the existing products. Following the SCOPS guidelines to carefully integrate Zolvix into worm control strategies, before the other groups fail, will allow our sheep industry to reap the full benefits of this new novel group."

A study carried out by Novartis in conjunction with the Hopkirk Research Institute showed that Zolvix treated sheep gained 33.5%, or 2.8 kg deadweight, more than sheep treated with a drench to which they were resistant.

Novartis Animal Health Brand Manager Simon Harris said: "Parasite resistance is a growing problem that decreases the productivity of sheep of all ages. Many veterinarians and farmers are concerned about this, with an increasing number of farmers reporting resistance to the three groups of wormers that have been available up to now, so the introduction of Zolvix is very timely."

At the same time, the company has also launched an award-winning new drenching system designed to offer 'a superior drenching experience for both animal and operator'. The new Optiline Drencher and Optivix backpack system were developed in collaboration with drenching specialists Simcro Tech Ltd.

The Optiline Drencher has already won several design and engineering awards, including a bronze award in the 2009 NZ BEST design awards, a coveted International Forum (IF) 2010 product design award from Germany and the prestigious Bayer Innovators Award for design and engineering.

It was also a finalist in the New Zealand Agritech Innovation Awards reached the finals in three categories of the 2009 New Zealand Trade and Enterprise International Business Awards.

The Optiline drencher is coupled with a durable, light Optivix backpack that has been specially tailored to provide left or right-handed operators with the same wide range of adjustment. It also has two drench cradles - at chest and hip level - to ensure maximum comfort.

Mr Harris said: "This drencher is best appreciated during use. Contact your local Novartis Animal health representative to arrange a trial."

Hill's Pet Nutrition has highlighted recent studies which, the company says, prove that feeding a food enriched with omega-3 fatty acids from fish oils to dogs with osteoarthritis results in a reduction in NSAID dosage of up to 25%¹, owner observed improvements in clinical signs³, and improved weight bearing ability^{2, 7}

The claim that food can effectively support medical treatment follows in the wake of two published and one in press study in the Journal of the American Veterinary Medicine Association (JAVMA). These demonstrate that omega-3 enriched food (in this case Hill's Prescription Diet j/d Canine) has significant  effects on weight bearing and helps reduce NSAID dosage by up to 25 per cent, when fed to dogs with osteoarthritis ^{1, 2,3}. 

According to Hill's, the research demonstrates that in dogs the high levels of eicosapentaenoic acid (EPA) from fish oils can down-regulate the cartilage degrading enzyme aggrecanase¹. In vitro studies have also identified that EPA resulted in a reduction in the amount of degraded cartilage residue produced⁴. High levels of omega-3 fatty acids can also help to reduce inflammation^5,6.

The two studies that were recently published confirm that feeding a diet rich in omega-3 fatty acids aids in the management of osteoarthritis in dogs^2,3. The randomized double-blinded controlled trials were carried out over three and six months respectively and involved a total of 165 dogs identified as suffering from mild to moderate osteoarthritis. After collating the results from almost 25,000 trial days, researchers were able to confirm a significant 'clinical improvement' from feeding a food fortified with fatty acids.

In the first study described in JAVMA, researchers found evidence that omega-3 fatty acids from fish oils resulted in improvements in weight bearing². Objective measurement using force plate gait analysis demonstrated that dogs fed a test food fortified with fatty acids were seven times as likely to show improved weight bearing compared with dogs fed a control food.

In the second study, through a detailed questionnaire, owners also observed significant improvements in their dog's osteoarthritic condition³.  Improvements observed covered the following signs: difficulty in rising from rest, limping, stiffness, soreness when touched, yelping or whimpering in pain, aggression, lagging on walks, reluctance to play and overall activity level.

Adrian Pratt, Veterinary Affairs Manager for Hill's Pet Nutrition, manufacturer of Prescription Diet j/d, which is enriched with omega-3 fatty acids, hailed the results as a breakthrough in the field of nutrigenomics (the study of the effects of nutrition on gene expression): "This research points the way to a new model for the management of osteoarthritis, using a clinically proven food to interrupt the cycle of damage and cartilage degradation, alongside graded levels of NSAIDs and proactive programmes to manage weight and adjust exercise routines. Clinicians now have the conclusive proof they need to recommend feeding omega-3 enriched food to ameliorate the signs of osteoarthritis in clients' pets and to adjust NSAID doses accordingly." 

For further information on Hill's Prescription Diet j/d, please contact your Hill's Territory Manager or call 0800 282438.

References
1. A multicenter study of the effect of a therapeutic food supplemented with fish oil omega-3 fatty acids on the Carpofen dosage in dogs with osteoarthritis. Fritsch A, Allen T, Dodd C, JAVMA in press
2. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs. Roush J, Cross A, Renberg W, Dodd C, Sixby K, Fritsch A, Allen T, Jewell, Richardson D, Leventhal P, Hahn K, JAVMA Vol 236 No 1, Jan 2010 pp67-73
3. Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. Roush J, Dodd C, Fritsch A, Allen T, Jewell D, Schoenherr W, Richardson D, Leventhal P, Hahn K, JAVMA Vol 236 No 1, Jan 2010 pp 59-66
4. Eicosapentaenoate supplementation abrogates canine articular cartilage degeneration in in vitro explant culture systems, Caterson B, Cramp J, Little C B et al, Hills European Symposium on osteoarthritis and joint health 2005 14-19
5.  Dietary modification of inflammation with lipids, P C Calder, Proceedings of the Nutrition Society 2002 345-358
6.  Dietary polyunsaturated fatty acids and inflammatory mediator production, James M J, Cleland L G, Gibson R A, Am J Clin Nut 2000: 71 suppl 343S- 358S
7.  Vasseur PB, Johnson AL, Budsberg SC, et al. Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs. J Am Vet Med Assoc 1995; 206 (6): 807-811.